19th Feb 2021 12:06
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 18 February 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,061,258 | 1.60% | 490,389 | 0.38% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
153,127 | 0.12% | 266,730 | 0.21% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
2,220,385 | 1.72% | 763,119 | 0.59% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 222.9350 USD |
Purchase | 5 | 224.0000 USD |
Purchase | 7 | 223.8364 USD |
Purchase | 100 | 225.1700 USD |
Purchase | 100 | 224.6300 USD |
Purchase | 100 | 224.1700 USD |
Purchase | 200 | 224.1481 USD |
Purchase | 313 | 224.0276 USD |
Purchase | 400 | 224.7125 USD |
Purchase | 600 | 225.1108 USD |
Purchase | 651 | 224.8275 USD |
Purchase | 750 | 226.4424 USD |
Purchase | 916 | 224.1165 USD |
Purchase | 1,155 | 224.3237 USD |
Purchase | 1,210 | 224.4180 USD |
Purchase | 1,400 | 224.9096 USD |
Purchase | 1,467 | 224.5527 USD |
Purchase | 1,627 | 223.4368 USD |
Purchase | 2,059 | 224.7906 USD |
Purchase | 2,300 | 223.9557 USD |
Purchase | 3,840 | 224.4910 USD |
Purchase | 5,060 | 224.1592 USD |
Purchase | 5,622 | 224.5142 USD |
Purchase | 6,379 | 222.9900 USD |
Purchase | 8,358 | 223.9684 USD |
Purchase | 9,215 | 224.0362 USD |
Purchase | 11,675 | 225.4879 USD |
Purchase | 29,031 | 224.3166 USD |
Purchase | 46,063 | 223.9889 USD |
Purchase | 70,900 | 224.3657 USD |
Purchase | 115,633 | 224.6407 USD |
Sale | 5 | 224.0000 USD |
Sale | 10 | 223.8500 USD |
Sale | 23 | 226.6500 USD |
Sale | 40 | 228.0400 USD |
Sale | 92 | 224.4854 USD |
Sale | 93 | 225.3600 USD |
Sale | 100 | 225.3500 USD |
Sale | 100 | 224.3800 USD |
Sale | 200 | 225.6750 USD |
Sale | 200 | 225.8575 USD |
Sale | 200 | 225.9750 USD |
Sale | 200 | 225.6900 USD |
Sale | 219 | 224.7023 USD |
Sale | 277 | 225.3336 USD |
Sale | 359 | 225.0800 USD |
Sale | 400 | 224.9900 USD |
Sale | 400 | 226.1737 USD |
Sale | 621 | 226.8530 USD |
Sale | 666 | 224.7051 USD |
Sale | 677 | 223.8374 USD |
Sale | 1,200 | 225.4300 USD |
Sale | 1,258 | 224.9366 USD |
Sale | 1,311 | 225.0458 USD |
Sale | 1,401 | 222.9900 USD |
Sale | 1,445 | 225.0945 USD |
Sale | 1,793 | 223.8755 USD |
Sale | 1,926 | 223.5745 USD |
Sale | 3,041 | 225.0593 USD |
Sale | 3,146 | 225.1207 USD |
Sale | 5,078 | 225.9263 USD |
Sale | 5,260 | 224.1683 USD |
Sale | 5,381 | 223.0087 USD |
Sale | 6,894 | 223.9960 USD |
Sale | 8,623 | 224.0157 USD |
Sale | 9,616 | 225.4781 USD |
Sale | 9,764 | 224.5690 USD |
Sale | 11,428 | 227.0201 USD |
Sale | 17,493 | 225.0927 USD |
Sale | 48,299 | 223.9927 USD |
Sale | 60,000 | 223.8666 USD |
Sale | 118,200 | 224.3829 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 19 Feb 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
| to which the option |
|
|
| |
| or derivative |
|
|
| |
| relates |
|
|
| |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210219005252/en/
Copyright Business Wire 2021
Related Shares:
Barclays